Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Gentamicin
Ecuphar NV
QS01AA11
Gentamicin
Gel
POM-V - Prescription Only Medicine – Veterinarian
Cats, Dogs
Antimicrobial
Expired
2001-11-23
Revised 26 November 2008 AN: 01133/2008 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Clinagel-Vet, gentamicin 0.30% w/w eye gel 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _ACTIVE SUBSTANCE(S)_ _% W/W_ Gentamicin 0.30 (as Gentamicin sulphate) _EXCIPIENT(S)_ Benzalkonium chloride 0.01 For full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Eye gel. Clear, colourless, viscous gel. 4. CLINICAL PARTICULARS 4.1. _TARGET SPECIES_ Dogs and cats. 4.2. _INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES_ Indicated for the treatment of infections of the external structures of the eyes and the eyelids caused by bacteria which are sensitive to gentamicin. These infections include bacterial conjunctivitis, keratitis and bacterial kerato- conjunctivitis, ulcers and abscesses of the cornea, blepharitis and blepharo- conjunctivitis, acute meibomitis and dacryocystitis. Treatment of infectious complications caused by foreign material in the cornea or conjunctiva and infections associated with traumata caused by a physical or chemical agent. 4.3. _CONTRA-INDICATIONS_ Hypersensitivity to one of the components of the product. 4.4. _SPECIAL WARNINGS FOR EACH TARGET SPECIES_ For use under veterinary supervision only. In cases of long-term treatment, re- examination should be performed at intervals (see also 4.5). Revised 26 November 2008 AN: 01133/2008 4.5. I. _SPECIAL PRECAUTIONS FOR USE_ _IN ANIMALS_ As is the case for other antibiotics, long term topical treatment can cause overgrowth of non-sensitive organisms such as fungi. Avoid contact between the tube and the eye. For external use only. Do not use concurrently with other antimicrobial ophthalmic products. Due to likely variability (time, geographical) in the occurrence of resistance of bacteria for Gentamicin sulphate, bacteriological sampling and susceptibility testing are recommended. II. _SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE _ _MEDICINAL PRODUCT TO THE ANIMALS_ People with known allergy (hypersensitiv Read the complete document